Phase 1/2 randomized clinical trial of intravenous infusion of umbilical cord mesenchymal stem cells in patients with chronic cardiopathy with stable heart failure (RIMECARD)
Event:
ESC Congress 2016
Topic:
Heart failure, other
Session:
Heart failure
